Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 205-319-0 | CAS number: 138-24-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- two-generation reproductive toxicity
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- secondary literature
- Justification for type of information:
- Data from secondary source
Data source
Reference
- Reference Type:
- secondary source
- Title:
- Robust Summaries & Test Plans for test material Joint Venture HPV Chemicals Challenge
- Author:
- Consumer Specialty Products Association (CSPA)
- Year:
- 2 011
- Bibliographic source:
- Robust Summaries & Test Plans for test material, Joint Venture HPV Chemicals Challenge 2011
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 416 (Two-Generation Reproduction Toxicity Study)
- Principles of method if other than guideline:
- Reproductive toxicity study of test material was performed on Sprague Dawley rats
- GLP compliance:
- not specified
- Limit test:
- no
- Justification for study design:
- No data available
Test material
- Reference substance name:
- Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides
- EC Number:
- 270-325-2
- EC Name:
- Quaternary ammonium compounds, benzyl-C12-16-alkyldimethyl, chlorides
- Cas Number:
- 68424-85-1
- Molecular formula:
- Unspecified
- IUPAC Name:
- Alkyl dimethyl benzyl ammonium chloride
- Details on test material:
- - Name of test material (as cited in study report):Alkyl dimethyl benzyl ammonium chloride
- Molecular formula:unspecified
- Molecular weight :368.0448g/mol
- Substance type: Organic
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Details on species / strain selection:
- No data available
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- No data available
Administration / exposure
- Route of administration:
- oral: feed
- Vehicle:
- not specified
- Details on exposure:
- Details on exposure
PREPARATION OF DOSING SOLUTIONS: test material mixed with feed
DIET PREPARATION
- Rate of preparation of diet (frequency):No data available
- Mixing appropriate amounts with (Type of food)
- Storage temperature of food: No data available
VEHICLE
- Justification for use and choice of vehicle (if other than water):
- Concentration in vehicle:
- Amount of vehicle (if gavage): No data available
- Lot/batch no. (if required): No data available
- Purity: No data available - Details on mating procedure:
- - M/F ratio per cage:1:1
- Length of cohabitation: three weeks
- Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as [day 0 / day 1] of pregnancy
- After ... days of unsuccessful pairing replacement of first male by another male with proven fertility.
- Further matings after two unsuccessful attempts: [no / yes (explain)]
- After successful mating each pregnant female was caged (how):
- Any other deviations from standard protocol: - Analytical verification of doses or concentrations:
- not specified
- Duration of treatment / exposure:
- F0: 19 weeks (from 1st prebreed dose to last F0
sacrifice)
F1: 24 weeks (from 1st F1 wean to last F1 sacrifice)
F2: to weaning
Premating exposure period for males: F0: 10 weeks; F1: 10 to 14 weeks (beginning with
1st weaning)
Premating exposure period for females: F0: 10 weeks; F1: 10 to 14 weeks (beginning with
1st weaning) - Frequency of treatment:
- 7 days/week
- Details on study schedule:
- After a 10-week pre-breed period rats were mated (one male to one female) for three weeks to produce the F1 generation. At weaning, 28 F1 weanlings/sex/group were selected to produce the F2 generation,After their pre-breed exposure, F1 animals were paired as described above. All procedures during mating, gestation, and lactation of the F1 parents and selected F2 weanlings were performed as described above.
Doses / concentrations
- Remarks:
- 0,300, 1000 and 2000 ppm ( Mean consumption for the males and females throughout the study was 22.5, 72.6 and 145.5 mg/kg/day for the 300, 1000 and 2000 ppm groups, respectively.
- No. of animals per sex per dose:
- Total:224
0 mg/kg/day:28 male and 28 female
23 mg/kg/day:28 male and 28 female
73 mg/kg/day:28 male and 28 female
145 mg/kg/day:28 male and 28 female - Control animals:
- yes, concurrent no treatment
- Details on study design:
- No data available
- Positive control:
- No data available
Examinations
- Parental animals: Observations and examinations:
- Parental animals observation and examinations
CAGE SIDE OBSERVATIONS: yes
DETAILED CLINICAL OBSERVATIONS: Yes
Time schedule: daily
BODY WEIGHT: Yes
Time schedule for examinations: daily
FOOD CONSUMPTION AND COMPOUND INTAKE (if feeding study): Yes Food consumption was determined weekly.
Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes / No / No data: No data available
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): No data
Time schedule for examinations:
OTHER: - Oestrous cyclicity (parental animals):
- No data available
- Sperm parameters (parental animals):
- No data available
- Litter observations:
- number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies were observed
- Postmortem examinations (parental animals):
- SACRIFICE
- Male animals: All surviving animals [describe when, e.g. as soon as possible after the last litters in each generation were produced.]
- Maternal animals: All surviving animals [describe when, e.g. after the last litter of each generation was weaned.]
GROSS NECROPSY: yes
- Gross necropsy consisted of [external and internal examinations including the cervical, thoracic, and abdominal viscera.]
HISTOPATHOLOGY / ORGAN WEIGHTS: yes
The tissues indicated in Table [#] were prepared for microscopic examination and weighed, respectively. - Postmortem examinations (offspring):
- SACRIFICE
- The F1 offspring not selected as parental animals and all F2 offspring were sacrificed at [#?] days of age.
- These animals were subjected to postmortem examinations (macroscopic and/or microscopic examination) as follows:
GROSS NECROPSY: yes
- Gross necropsy consisted of [external and internal examinations including the cervical, thoracic, and abdominal viscera.]
HISTOPATHOLOGY / ORGAN WEIGTHS: yes
The tissues indicated in Table [#] were prepared for microscopic examination and weighed, respectively. - Statistics:
- The results of the quantitative continuous variables (e.g., body weights, food consumption, etc.) were compared for the three treatment groups and one control group by use of Levene’s test for equal variances, analysis of variance and (pooled or separate variance) t-test. Non-parametric data were statistically evaluated using the Kruskall-Wallis test followed by the Mann-Whitney U test for pairwise comparisons when appropriate. Frequency data were compared using the Fisher’s exact test.
- Reproductive indices:
- No data available
- Offspring viability indices:
- No data available
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Males exhibited no reduction in body weight. Females at 2000 ppm had reductions in body weight for weeks 5, 6, 9 and 10 of treatment. Body weight gain was reduced at 2000 ppm for one week during the prebreed treatment. Food consumption in F0 females at 2000 ppm was reduced for the first four exposure weeks.
Females in the 2000 ppm group showed significant reductions in body weights on day 0 of gestation, but no body weight gain reductions. Body weight gains throughout lactation and body weights on lactation day 21 were increased in the females in the 2000 ppm group. - Food consumption and compound intake (if feeding study):
- no effects observed
- Description (incidence and severity):
- During gestation and lactation was unaffected by test substance treatment.
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- No treatment-related lesions were observed in the necropsy of F0 males and females. No treatment-related lesions were observed in the
histopathologic examination of selected organs from F0 males and females at 2000 ppm. - Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- Reproductive parameters were unaffected by treatment.
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- 145 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- food consumption and compound intake
- histopathology: non-neoplastic
- reproductive performance
- Remarks on result:
- other: No effects on reproductive parameters were observed
Target system / organ toxicity (P0)
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Treatment related:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
Results: P1 (second parental generation)
General toxicity (P1)
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- no mortality observed
- Description (incidence):
- There were no apparent treatment-related deaths of adult animals on study.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- F1 males at 2000 ppm exhibited no reduction in body weights but did have reduced weight gain in the second treatment week.
- Food consumption and compound intake (if feeding study):
- effects observed, treatment-related
- Description (incidence and severity):
- Food consumption was reduced for F1 males at 2000 ppm for two of the 10 treatment weeks. There were no significant effects on F1 females.
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Neuropathological findings:
- not specified
- Histopathological findings: non-neoplastic:
- no effects observed
- Description (incidence and severity):
- No treatment-related lesions were observed in the necropsy of F1 males and females.
There were no treatment-related lesions observed in the histopathologic examination of selected organs from the 2000 ppm group. - Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
Reproductive function / performance (P1)
- Reproductive function: oestrous cycle:
- not specified
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- Reproductive parameters were unaffected by treatment. Maternal body weights at 2000 ppm were unaffected during the gestational and lactational periods. Gestational food consumption was reduced for days 7 - 11 and 14 - 17 at 2000 ppm.
Effect levels (P1)
- Dose descriptor:
- NOAEL
- Effect level:
- 145 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- mortality
- body weight and weight gain
- food consumption and compound intake
- histopathology: non-neoplastic
- reproductive performance
- Remarks on result:
- other: Reproductive parameters were unaffected by treatment.
Target system / organ toxicity (P1)
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Treatment related:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- no mortality observed
- Description (incidence and severity):
- No effects of treatment on postnatal deaths (postnatal days 0 - 28) were observed.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Pups exhibited reduced body weights per litter on days 21 (weaning) and 28 (postweaning) at 2000 ppm. F1 pup body weight gains were reduced for lactation days 14 - 21 and 21 - 28 (postweaning).
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Histopathological findings:
- no effects observed
- Description (incidence and severity):
- No treatment-related lesions were observed in the necropsy of F1 pups that died during lactation or of randomly selected F1 pups (10/sex/dose)
- Other effects:
- not specified
Developmental neurotoxicity (F1)
- Behaviour (functional findings):
- not specified
Developmental immunotoxicity (F1)
- Developmental immunotoxicity:
- not specified
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 73 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- viability
- mortality
- body weight and weight gain
- histopathology: non-neoplastic
- Remarks on result:
- other: Pups exhibited reduced body weights per litter on days 21 (weaning) and 28 (postweaning) at 2000 ppm. F1 pup body weight gains were reduced for lactation days 14 - 21 and 21 - 28 (postweaning).
Target system / organ toxicity (F1)
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Treatment related:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
Results: F2 generation
General toxicity (F2)
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- no mortality observed
- Description (incidence and severity):
- Perinatal deaths and lactational survival were unaffected by treatment.
- Description (incidence and severity):
- Pup body weights per litter were reduced at 2000 ppm at postnatal day 28 (postweaning). Pup weight gains per litter also were reduced at 2000 ppm for lactational days 14 - 21 (preweaning) and for days 21 - 28 (postweaning).
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- not specified
- Histopathological findings:
- no effects observed
- Description (incidence and severity):
- There were no treatment-related lesions observed in the necropsy of F2 pups that died during lactation or of randomly selected F2 pups
(10/sex/group) - Other effects:
- not specified
Developmental neurotoxicity (F2)
- Behaviour (functional findings):
- not specified
Developmental immunotoxicity (F2)
- Developmental immunotoxicity:
- not specified
Effect levels (F2)
- Dose descriptor:
- NOAEL
- Generation:
- F2
- Effect level:
- 73 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- not specified
- Basis for effect level:
- viability
- mortality
- body weight and weight gain
- histopathology: non-neoplastic
- Remarks on result:
- other: No developmental toxic effects observed
Target system / organ toxicity (F2)
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Treatment related:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
- Treatment related:
- not specified
- Relation to other toxic effects:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
Applicant's summary and conclusion
- Conclusions:
- No Observed Adverse Effect Level (NOAEL) for reproductive toxicity was considered to beapproximately 145 mg/kg/day (2000ppm)and for developmental toxicity considered to be approximately 73mg/kg /day(1000ppm). When male and female SpragueDawley rats were treated with test material orally.
- Executive summary:
The two generation reproductive toxicity of test material was performed on male and female SpragueDawley rats. The test material mixed with feed in dose concentration 300, 1000 and 2000 ppm (approximately 22.5, 72.6 and 145.5 mg/kg/day base on Mean consumption for the males and females throughout the study). A total of 28 male and 28 female rats were evaluated at each dose level. After a 10-week pre-breed period rats were mated (one male to one female) for three weeks to produce the F1 generation. Exposures continued through mating, gestation, parturition and lactation. At weaning, 28 F1 weanlings/sex/group were selected to produce the F2 generation, and were then exposed to the same dietary concentrations of test material as their parents for 10 weeks. After their pre-breed exposure, F1 animals were paired as described above. All procedures during mating, gestation, and lactation of the F1 parents and selected F2 weanlings were performed as described above. All F0 and F1 parental animals were necropsied and examined for gross lesions; selected reproductive tissues from the high dose and control groups were examined histologically as were other tissues with gross lesions. Ten F1 and F2 weanlings/sex/group were randomly selected and examined for gross lesions. Remaining nonselected F1 and F2 pups at weaning were euthanized and discarded after the necropsy of the selected pups.
After 10 weeks Premating Exposure for paraents males exhibited no reduction in body weight. Females at 2000 ppm had reductions in body weight for weeks 5, 6, 9 and 10 of treatment. Body weight gain was reduced at 2000 ppm for one week during the prebreed treatment. Food consumption in F0 females at 2000 ppm was reduced for the first four exposure weeks. While Reproductive parameters were unaffected by treatment. Females in the 2000 ppm group showedsignificant reductions in body weights on day 0 of gestation, but no body weight gain reductions.Body weight gains throughout lactation and body weights on lactation day 21 were increased in thefemales in the 2000 ppm group. Food consumption during gestation and lactation was unaffected bytest substance treatment during gestation and lactation period in F0 Female. After postmortem .No treatment-related lesions were observed in the necropsy of F0 males and females. No treatment-related lesions were observed in the histopathologic examination of selected organs from F0 males and females at 2000 ppm.
F1 males at 2000 ppm exhibited no reduction in body weights but did have reduced weight gain in the second treatment week. Food consumption was reduced for F1 males at 2000 ppm for two of the 10 treatment weeks. There were no significant effects on F1 females. Reproductive parameters were unaffected by treatment. Maternal body weights at 2000 ppm were unaffected during the gestational and lactational periods. Gestational food consumption was reduced for days 7 - 11 and 14- 17 at2000 ppm. After postmortem in F1 male and female .No treatment-related lesions were observed in the necropsy of F1 males and females. There were no treatment-related lesions observed in the histopathologic examination of selected organs from the 2000 ppm group. There were no apparenttreatment-related deaths of adult animals on study.
In F1 litter,Pups exhibited reduced body weights per litter on days 21 (weaning) and 28 (postweaning) at 2000 ppm. F1 pup body weight gains were reduced for lactation days 14 - 21 and 21 – 28 (postweaning). No effects of treatment on postnatal deaths (postnatal days 0 - 28) were observed. No treatment-related lesions were observed in the necropsy of F1 pups that died during lactation or of randomly selected F1 pups (10/sex/dose).While in F2 Litters,Pup body weights per litter were reduced at 2000 ppm at postnatal day 28 (postweaning). Pup weight gains per litter also were reduced at 2000 ppm for lactational days 14 - 21 (preweaning) and for days 21 - 28 (postweaning). Perinatal deaths and lactational survival were unaffected by treatment. There were no treatment-related lesions observed in the necropsy of F2 pups that died during lactation or of randomly selected F2 pups (10/sex/group).
Exposure of rats to the test substance in the diet for two generations resulted in parental toxicityat the target dose level of 145mg/kg bw/day (2000 ppm): perinatal toxicity was concomitant with parental toxicity, being well-defined at 145mg/kg bw/day (2000 ppm.There were notreatment-related reproductive effects observed in this study. The A/D ratio (the dose level at which there were no observable effects in adults/the dose level at which there were no observable effects on offspring) is 1 (1000 ppm/1000 ppm) indicating no increased risk to the offspring in the absence of indications of adult toxicity. HenceNo Observed Adverse Effect Level (NOAEL) for reproductive toxicity was considered to beapproximately 145 mg/kg/day (2000ppm)and for developmental toxicity considered to be approximately 73mg/kg /day(1000ppm). When male and femaleSpragueDawley rats were treated withtest materialorally.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.